Nama Insights

Procter & Gamble (PG)

Consumer Defensive · Household Personal Products · NYSE

S&P 500
Procter & Gamble (PG) is a Consumer Defensive company in the Household Personal Products industry. It has a market capitalization of $383.36B, a trailing price-to-earnings ratio of 24.0 and a free-cash-flow yield of 3.8%. Over the most recent reported fiscal year, revenue grew 3.3% and free cash flow per share grew 9.3%. Nama's AI scorecard rates it Buy, 6.3 out of 10. On 12-month momentum it ranks in the middle band of its market.
AI scorecard
Buy · 6.3/10
Positive, at the low end of Buy. As of Nov 7, 2026.
Momentum
Middle · +1.2% over 12 months ex. last
Middle fifth of its market on the past year's move.
Shariah screen
Shariah Compliant
Passes our debt, cash and income screen; not a scholar's ruling.
Off its high
-8.3%
How far the last close sits under the highest price of the past five years.
Market cap$383.36B
Trailing P/E24.0
Price / book7.0
Price / sales4.4
FCF yield3.8%
Dividend yield2.6%
Gross margin49.8%
Operating margin22.6%
Net margin18.2%
Revenue growth (YoY)+3.3%
Revenue growth (3-yr annual)+2.0%
EPS growth (YoY)+0.9%
FCF/share growth (YoY)+9.3%
Beta0.4
ExchangeNYSE
SectorConsumer Defensive
IndustryHousehold Personal Products

PG earnings

Next report: Jan 21, 2027 (Q2 2027, EPS estimate $1.81). Beat the EPS estimate in 4 of 4 recent quarters.

QuarterReportedEPSEstimateSurpriseRevenue
Q1 2027 Oct 22, 2026 $2.00 $1.89 +5.8% $23.28B
Q4 2026 Jul 29, 2026 $1.43 $1.41 +1.4% $21.20B
Q3 2026 Apr 24, 2026 $1.59 $1.56 +1.9% $21.23B
Q2 2026 Jan 22, 2026 $1.88 $1.86 +1.1% $22.21B

PG analyst price target

Median target $176.00 from 23 analysts, ranging $151.00 – $190.00.

Household Personal Products peers

TickerCompanyMarket capP/E
UL Unilever $142.12B 44.0
CL Colgate-Palmolive $76.76B 24.9
KMB Kimberly-Clark $66.54B 14.2
EL Estée Lauder Companies $39.88B 37.8
KVUE Kenvue $37.11B 16.2
CHD Church & Dwight $25.81B 30.2
CLX Clorox $12.09B 16.0
ELF e.l.f. Beauty $6.86B 25.7
Explore live PG data on Nama Insights →

Recent Congressional trades

Procter & Gamble trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Maria Elvira Salazar House Buy $1,001 - $15,000 Nov 5, 2026
Pete Sessions House Sell $1,001 - $15,000 Oct 27, 2026
David J. Taylor House Sell $1,001 - $15,000 Oct 15, 2026
Lloyd Doggett House Buy $1,001 - $15,000 Sep 8, 2026
Kevin Hern House Sell $50,001 - $100,000 Sep 1, 2026
Kevin Hern House Sell $1,001 - $15,000 Sep 1, 2026
David J. Taylor House Buy $1,001 - $15,000 Aug 20, 2026
Richard Dean McCormick House Sell $1,001 - $15,000 Aug 14, 2026
Thomas H Tuberville Senate Sell $1,001 - $15,000 Aug 5, 2026
Alan Armstrong Senate Sell $15,001 - $50,000 Jul 21, 2026
Thomas H Tuberville Senate Sell $15,001 - $50,000 Jul 16, 2026
Richard W. Allen House Sell $15,001 - $50,000 Jun 5, 2026

PG FAQ

Is PG a buy?
Nama's AI scorecard currently rates Procter & Gamble Buy (6.3 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is PG's P/E ratio?
Procter & Gamble trades at a trailing price-to-earnings ratio of 24.0.
When does PG report earnings?
Procter & Gamble's next scheduled report is on Jan 21, 2027. Analysts expect EPS of $1.81.
What is the PG price target?
The median analyst price target from 23 analysts is $176.00, with a range of $151.00 – $190.00.
Is PG Shariah compliant?
Nama's AAOIFI-style screen reads Procter & Gamble as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does PG pay a dividend?
Yes — Procter & Gamble's dividend yield is 2.6%.